Back
Vertex Pharmaceuticals Quote, Financials, Valuation and Earnings
Sponsored
VRTX
Sponsored
20 Most Hated Stocks on Wall Street
Click here to see the full list and protect yourself before it's too late.
Buy
62
VRTX
Vertex Pharmaceuticals
Last Price:
400.09
Seasonality Move:
10.13%
7 Day Trial
ALL ACCESS PASS
$
7
9,530x the last time this happened
Here's what our expert says you should buy before April 14.Vertex Pharmaceuticals Price Quote
$400.09
-2.09 (-0.52%)
(Updated: May 2, 2024 at 6:55 PM ET)
Vertex Pharmaceuticals Key Stats
Buy
62
Vertex Pharmaceuticals (VRTX)
is a Buy
Day range:
$392.47 - $406.95
52-week range:
$320.01 - $448.40
Dividend yield:
0%
P/E ratio:
28.52
P/S ratio:
10.46
P/B ratio:
5.82%
Volume:
1M
Avg. volume:
948.2K
1-year change:
16.57%
Market cap:
$102.3B
Revenue:
$9.9B
EPS:
$13.89
How Much Does Vertex Pharmaceuticals Make?
-
How Much Are Vertex Pharmaceuticals's Sales Annually?
VRTX Revenues are $9.9B -
How Much Profit Does Vertex Pharmaceuticals's Make A Year?
VRTX net income is $3.6B
Is Vertex Pharmaceuticals Growing As A Company?
-
What Is Vertex Pharmaceuticals's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.09% -
What Is Vertex Pharmaceuticals's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0.18%
Vertex Pharmaceuticals Stock Price Performance
-
Did Vertex Pharmaceuticals Stock Go Up Last Month?
Vertex Pharmaceuticals share price went down by -4.35% last month -
Did VRTX's Share Price Rise Over The Last Year?
VRTX share price rose by 16.57% over the past 1 year
What Is Vertex Pharmaceuticals 52-Week High & Low?
-
What Is Vertex Pharmaceuticals’s 52-Week High Share Price?
Vertex Pharmaceuticals has traded as high as $448.40 over the past 52 weeks -
What Is Vertex Pharmaceuticals’s 52-Week Low Share Price?
Vertex Pharmaceuticals has traded as low as $320.01 over the past 52 weeks
Vertex Pharmaceuticals Price To Free Cash Flow
-
Is Vertex Pharmaceuticals Stock Overvalued?
Vertex Pharmaceuticals is trading at a price to free cash flow ratio of 31.48 -
Is Vertex Pharmaceuticals Stock Undervalued?
Vertex Pharmaceuticals EV to Free Cash Flow ratio is 27.79 -
What Is Vertex Pharmaceuticals’s Price Earnings Growth Ratio?
VRTX PEG ratio is 3.45 -
Is Vertex Pharmaceuticals Trading At A Premium To Earnings?
Vertex Pharmaceuticals EV to EBIT ratio is 20.60
Is It Risky To Buy Vertex Pharmaceuticals?
-
How Much Debt Does Vertex Pharmaceuticals Have?
Total long term debt quarterly is $0 -
How Much Cash Does Vertex Pharmaceuticals Have?
Cash and short term investments quarterly total is $11.2B -
What Is Vertex Pharmaceuticals’s Book Value Per Share?
Book value per share is 68.22
Is Vertex Pharmaceuticals Cash Flow Positive?
-
What Is VRTX Cash Flow From Operations?
Cash flow from operations (TTM) is $3.5B -
What Is Vertex Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$562.2M -
What Is Vertex Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$3.1B
Vertex Pharmaceuticals Return On Invested Capital
-
Is Management Doing A Good Job?
VRTX return on invested capital is 23.23% -
What Is Vertex Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is 17.76% -
What Is VRTX Return On Equity?
ROE is a measure of profitability and is 23.23%
Vertex Pharmaceuticals Earnings Date & Stock Price
-
What Is Vertex Pharmaceuticals's Stock Price Today?
A single share of VRTX can be purchased today for 402.18 -
What Is Vertex Pharmaceuticals’s Stock Symbol?
Vertex Pharmaceuticals trades on the S&P500 under the ticker symbol: VRTX -
When Is Vertex Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for Vertex Pharmaceuticals is scheduled on May 6, 2024 -
When Is VRTX's next ex-dividend date?
Vertex Pharmaceuticals's next ex-dividend date is May 3, 2024 -
How To Buy Vertex Pharmaceuticals Stock?
You can buy Vertex Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Vertex Pharmaceuticals Competitors
-
Who Are Vertex Pharmaceuticals's Competitors?
Below is a list of companies who compete with Vertex Pharmaceuticals or are related in some way:
Vertex Pharmaceuticals Dividend Yield
Data Unavailable
Vertex Pharmaceuticals Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 17.78% | 2.78% |
Revenue: | 9.34% | 0.12% |
Analyst Recommendations
Buy Recommendations: | 14 |
---|---|
Hold Recommendations: | 10 |
Sell Recommendations: | 2 |
Price Target: | 459.72 |
Upside from Last Price: | 14.31% |